Vosevi ™ for the Retreatment of Chronic Hepatitis C Virus Infection

Vosevi ™ (Sofosbuvir/Velpatasvir/Voxilaprevir) is a direct-acting antiviral (DAA) indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults with genotypes one to six.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news